Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia.

Hyperprolactinemia cannulated prolactin prolactinoma venipuncture stress

Journal

Clinical medicine insights. Endocrinology and diabetes
ISSN: 1179-5514
Titre abrégé: Clin Med Insights Endocrinol Diabetes
Pays: United States
ID NLM: 101578235

Informations de publication

Date de publication:
2021
Historique:
received: 28 10 2020
accepted: 27 05 2021
entrez: 5 7 2021
pubmed: 6 7 2021
medline: 6 7 2021
Statut: epublish

Résumé

Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprolactinema and may result in patients having unnecessary investigations and imaging. We report the results of cannulated prolactin tests with serial prolactin measurements from an indwelling catheter to differentiate true from stress-induced hyperprolactinemia in patients with persistently mildly elevated prolactin levels in both referral and repeat samples. Data were collected for 42 patients who had a cannulated prolactin test between January 2017 and May 2018. After cannula insertion, prolactin was measured at 0, 60, and 120 minutes. Normalization is defined as a decline in prolactin to gender-defined normal ranges. The mean age was 33.8 years ( The cannulated prolactin test was useful in excluding true hyperprolactinemia in 28.6% of patients with previously confirmed mildly elevated random prolactin on two occasions, thus avoiding over-diagnosis and unnecessary imaging.

Sections du résumé

BACKGROUND BACKGROUND
Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprolactinema and may result in patients having unnecessary investigations and imaging. We report the results of cannulated prolactin tests with serial prolactin measurements from an indwelling catheter to differentiate true from stress-induced hyperprolactinemia in patients with persistently mildly elevated prolactin levels in both referral and repeat samples.
METHODS METHODS
Data were collected for 42 patients who had a cannulated prolactin test between January 2017 and May 2018. After cannula insertion, prolactin was measured at 0, 60, and 120 minutes. Normalization is defined as a decline in prolactin to gender-defined normal ranges.
RESULTS RESULTS
The mean age was 33.8 years (
CONCLUSION CONCLUSIONS
The cannulated prolactin test was useful in excluding true hyperprolactinemia in 28.6% of patients with previously confirmed mildly elevated random prolactin on two occasions, thus avoiding over-diagnosis and unnecessary imaging.

Identifiants

pubmed: 34220205
doi: 10.1177/11795514211025276
pii: 10.1177_11795514211025276
pmc: PMC8221679
doi:

Types de publication

Journal Article

Langues

eng

Pagination

11795514211025276

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Clin Biochem Rev. 2018 Feb;39(1):3-16
pubmed: 30072818
Obstet Gynecol Int. 2018 Dec 3;2018:9253083
pubmed: 30627169
Ann Endocrinol (Paris). 2007 Feb;68(1):34-8
pubmed: 17316543
N Y State J Med. 1989 Apr;89(4):205-8
pubmed: 2733871
Gynecol Endocrinol. 2015 Jul;31(7):506-10
pubmed: 26291795
Endocr Pract. 2020 Nov;26(11):1304-1311
pubmed: 33471661
Int J Gynaecol Obstet. 1985 Dec;23(6):459-62
pubmed: 2868939
Neuroendocrinology. 2019;109(1):7-19
pubmed: 30889571
Pituitary. 2015 Jun;18(3):319-25
pubmed: 24879500
Endocr Pract. 2015 Dec;21(12):1427-35
pubmed: 26642103
Harefuah. 1998 Nov 1;135(9):348-50, 408, 407
pubmed: 10911442
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88
pubmed: 21296991
Endocrinol Metab Clin North Am. 2008 Mar;37(1):151-71, xi
pubmed: 18226735
Clin Endocrinol (Oxf). 2006 Aug;65(2):265-73
pubmed: 16886971
Int J Environ Res Public Health. 2020 Nov 06;17(21):
pubmed: 33171973

Auteurs

Raya Almazrouei (R)

Department of Diabetes & Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
Division of Endocrinology, Tawam Hospital, Al Ain, United Arab Emirates.

Shamaila Zaman (S)

Department of Diabetes & Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Florian Wernig (F)

Department of Diabetes & Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Karim Meeran (K)

Department of Diabetes & Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.

Classifications MeSH